JPH0956813A - Red cell-removing system - Google Patents

Red cell-removing system

Info

Publication number
JPH0956813A
JPH0956813A JP7238968A JP23896895A JPH0956813A JP H0956813 A JPH0956813 A JP H0956813A JP 7238968 A JP7238968 A JP 7238968A JP 23896895 A JP23896895 A JP 23896895A JP H0956813 A JPH0956813 A JP H0956813A
Authority
JP
Japan
Prior art keywords
tube
filter means
liquid
cell
tubes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP7238968A
Other languages
Japanese (ja)
Other versions
JP3722523B2 (en
Inventor
Masaya Sumida
政哉 澄田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Medical Co Ltd
Original Assignee
Asahi Medical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Medical Co Ltd filed Critical Asahi Medical Co Ltd
Priority to JP23896895A priority Critical patent/JP3722523B2/en
Publication of JPH0956813A publication Critical patent/JPH0956813A/en
Application granted granted Critical
Publication of JP3722523B2 publication Critical patent/JP3722523B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To make it possible to easily and rapidly make the operation to remove red cells from a raw material cell liquid at a low cost without using a centrifugal separator and special reagent and to make aseptic operation. SOLUTION: This red cell-removing system includes a recovered liquid storage section 4 which is respectively connected with a means 1 for storing the drawn raw material cell liquid, a filter means 2 for allowing the passage of the red cells and capturing the white cells and a means 3 for storing the red cell-contg. liquid flowing out of this filter means 3 respectively in series via first and second tubes and is connected to a third tube 8 branched from a second tube 7 downstream of the filter means and a white blood recovery section 5 which is connected to a fourth tube 9 branched from a first tube 6 upstream of the filter means. Further, the system has the means for passing the liquid only toward the filter means 2 from a recovered liquid storage section 4 at the branching point of the second and third tubes and the means for passing the liquid only toward a white cell recovery section 4 from the filter means 2 at the branching point of the first and fourth tubes.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は骨髄あるいは末梢血など
の、赤血球と造血幹細胞及び/または造血前駆細胞を含
む細胞集団から、赤血球を除去するシステムに関する。
TECHNICAL FIELD The present invention relates to a system for removing red blood cells from a cell population such as bone marrow or peripheral blood containing red blood cells and hematopoietic stem cells and / or hematopoietic progenitor cells.

【0002】[0002]

【従来の技術】現在、白血病などの造血器腫瘍及び固形
癌の化学療法における主たる副作用である造血障害に対
して、骨髄移植法あるいは、末梢血を用いる末梢血幹細
胞移植療法が行われている。周知の通り、これら移植療
法における同種移植を行う際はドナーとレシピエント
(患者)間のHLA(白血球の血液型)の一致が最も重
要であるため、ABO血液型(赤血球の血液型)の違い
はドナー骨髄または末梢血から赤血球を除去することで
解決している。従来、赤血球を除去する手段として遠心
分離器により、移植に必要とされる造血幹細胞及び/ま
たは造血前駆細胞を含む白血球分画(更に詳しくは単核
球分画)と赤血球分画に分離する方法が行われている。
特に効果的に赤血球と単核球を分離したい場合は密度勾
配遠心法と呼ばれる比重液(例えば、ファルマシア社製
Ficoll)を用いた遠心方法を行うが、その操作過
程は比重液に細胞浮遊液を重層する際に決して液面を乱
してはならない等熟練を要し煩雑である。しかも、比重
液を用いるためコスト高である。特開昭61−8455
7号公報、特開平2−134564号公報等で操作の煩
雑さを解決すべく、多くの試みがなされているが、いま
だ簡便で低コスト且つ短時間で骨髄から赤血球を除去す
る技術はない。
2. Description of the Related Art At present, a bone marrow transplantation method or a peripheral blood stem cell transplantation therapy using peripheral blood is performed for hematopoietic disorders, which are main side effects in chemotherapy of hematopoietic tumors such as leukemia and solid cancer. As is well known, when performing allogeneic transplantation in these transplantation therapies, the matching of HLA (white blood cell type) between the donor and the recipient (patient) is the most important. Has been resolved by removing red blood cells from donor bone marrow or peripheral blood. Conventionally, a method of separating a white blood cell fraction (more specifically, mononuclear cell fraction) containing hematopoietic stem cells and / or hematopoietic progenitor cells required for transplantation and a red blood cell fraction by a centrifuge as a means for removing red blood cells Is being done.
When it is desired to separate erythrocytes and mononuclear cells particularly effectively, a centrifugation method using a specific gravity liquid called density gradient centrifugation (for example, Ficoll manufactured by Pharmacia) is carried out. The operation process involves adding a cell suspension to the specific gravity liquid. It is complicated and requires skill such as never disturbing the liquid surface when stacking layers. Moreover, the cost is high because a specific gravity liquid is used. JP 61-8455
Although many attempts have been made to solve the complexity of operations in Japanese Patent Laid-Open No. 7-134564, Japanese Patent Laid-Open No. 2-134564, etc., there is still no technique for removing erythrocytes from bone marrow in a simple, low-cost and short time.

【0003】[0003]

【発明が解決しようとする課題】本発明の目的は、遠心
分離器や特殊な試薬を用いることなく、簡便で低コスト
で短時間で操作でき、且つ無菌操作ができる赤血球除去
システムを提供することにある。
SUMMARY OF THE INVENTION It is an object of the present invention to provide a red blood cell removal system which is simple, can be operated at low cost in a short time, and can be operated aseptically without using a centrifuge or a special reagent. It is in.

【0004】[0004]

【課題を解決するための手段】図1は、本発明の赤血球
除去システムの概略図である。本発明は、採取された原
料細胞液を貯留する手段1と、赤血球は通過し白血球は
捕捉するフィルター手段2と、該フィルター手段2より
流出した赤血球含有液を貯留する手段3とがそれぞれ第
1及び第2のチューブを介して直列に接続されており、
前記フィルター手段下流の第2のチューブ7から分岐し
た第3のチューブ8に接続する回収液貯留部4と、前記
フィルター手段上流の第1のチューブ6から分岐した第
4のチューブ9に接続する白血球回収部5を具備し、且
つ第2と第3のチューブの分岐点には前記回収液貯留部
4からフィルター手段2の方向のみへ流通せしめるため
の手段を、第1と第4のチューブの分岐点には前記フィ
ルター手段2から前記白血球回収液部5の方向のみへ流
通せしめるための手段を有することを特徴とする赤血球
除去システムに関する。更に、白血球回収前に該フィル
ター手段をリンスせしめるための手段を有する赤血球除
去システムに関する。本発明に用いるフィルター手段と
してはナイロンウール、ポリエステル不織布、ハイドロ
キシアパタイトビーズ、スポンジ状高分子化合物などが
あげられるがこれらに限定されるものではなく、白血球
を捕捉した後、その白血球回収ができる素材であればよ
い。但し、同種骨髄移植における合併症の原因細胞除
去、あるいは自家骨髄移植における癌細胞除去を目的と
した細胞分離分野で分離効率を上げるため赤血球ととも
に血小板も除去されることが望まれる場合には、本発明
のフィルター手段に血小板を通過させるコーティング処
理等で表面電荷を調整する。本発明で言う第2と第3及
び第1と第4のそれぞれのチューブ分岐点に有する一方
向へ流通せしめるための手段としては三方活栓、デュア
ルチェックバルブ、クランプ等が挙げられるが三方活栓
を用いるのが望ましい。更に、回収溶液貯留部4には、
フィルター手段に捕捉された白血球を回収するための回
収液を入れている。該回収液としては生理食塩水、HB
SS(ハンクス液)、D−PBS(ダルベッコーリン酸
緩衝液)などの緩衝液にヒト血清アルブミンなどのタン
パクあるいは抗凝固剤を必要に応じて添加したものが用
いられる。また、本発明で用いる原料細胞液とは赤血
球、造血幹細胞及び/または造血前駆細胞を含む液体で
あり、骨髄、末梢血、臍帯血あるいはこれらを遠心分離
器により粗分離したものが挙げられる。今後、幹細胞増
幅法を利用して少量の造血幹細胞を培養し移植する技術
の発展とともに、赤血球除去の有無性は一層高まるもの
と考えられる。
FIG. 1 is a schematic diagram of the red blood cell removal system of the present invention. According to the present invention, the means 1 for storing the collected raw material cell fluid, the filter means 2 for passing the red blood cells and capturing the white blood cells, and the means 3 for storing the red blood cell-containing liquid flowing out from the filter means 2 are respectively the first. And connected in series via the second tube,
Recovery liquid reservoir 4 connected to a third tube 8 branched from the second tube 7 downstream of the filter means, and white blood cells connected to a fourth tube 9 branched from the first tube 6 upstream of the filter means. At the branch point of the second and third tubes, a means for circulating the collected liquid storage section 4 only in the direction of the filter means 2 is provided at the branch point of the first and fourth tubes. The point relates to an erythrocyte removal system characterized in that it has means for allowing the filter means 2 to flow only in the direction of the white blood cell recovery liquid part 5. Furthermore, it relates to a red blood cell removal system having means for rinsing the filter means before leukocyte recovery. Examples of the filter means used in the present invention include, but are not limited to, nylon wool, polyester non-woven fabric, hydroxyapatite beads, sponge-like polymer compounds, and the like. I wish I had it. However, if it is desired to remove platelets along with erythrocytes in order to improve the separation efficiency in the field of cell separation for the purpose of removing cells causing complications in allogeneic bone marrow transplantation or in removing cancer cells in autologous bone marrow transplantation, The surface charge is adjusted by a coating treatment or the like for passing platelets through the filter means of the invention. Examples of means for unidirectionally circulating the second and third tubes and the first and fourth tube branch points referred to in the present invention include three-way stopcocks, dual check valves, clamps, etc., but three-way stopcocks are used. Is desirable. Furthermore, in the collected solution storage section 4,
The filter means contains a recovery liquid for recovering the captured white blood cells. As the recovery liquid, physiological saline, HB
A buffer such as SS (Hanks's solution) or D-PBS (Dulbecco's phosphate buffer) to which a protein such as human serum albumin or an anticoagulant is added as needed is used. Further, the raw material cell liquid used in the present invention is a liquid containing red blood cells, hematopoietic stem cells and / or hematopoietic progenitor cells, and examples thereof include bone marrow, peripheral blood, cord blood, and those roughly separated by a centrifuge. It is considered that the presence / absence of erythrocyte removal will be further enhanced with the development of the technique of culturing and transplanting a small amount of hematopoietic stem cells using the stem cell expansion method in the future.

【0005】[0005]

【実施例1】本発明の実施態様の1例を図面により説明
する。1は原料細胞が入った容器(通常、血液バッグ)
であり第1のチューブ6と接続している。4は回収液の
入っているバッグであり、ここから白血球除去フィルタ
ー2に回収液を供給する。第3のチューブ8はフィルタ
ー手段2に回収液を供給するチューブで第2のチューブ
7に連結している。なお、第3のチューブの途中にはク
ランプ14が、また、第3のチューブ8と第2のチュー
ブ7の分岐点には三方活栓12がある。チューブ10は
リンス液をフィルター手段2に導入するチューブであ
り、第1のチューブ6からY字管等により分岐してい
る。チューブ10の途中にはクランプ13がある。第1
のチューブ6にクランプ16、メッシュ入りトラップ1
5があるものが望ましい。第4のチューブ9は回収細胞
液を白血球回収部5に導入するためのものである。第1
のチューブ6と第4のチューブ9の分岐点には三方活栓
11がある。フィルター手段2は、赤血球は(血小板を
除去したい場合は血小板も)通過するが、白血球は捕捉
するフィルターである。それぞれの1、3、4、5の手
段に用いるバッグは、スパイクあるいは無菌接続器でチ
ューブと接続可能となっている。次に使用方法を説明す
る。まず、常法により採取された骨髄、末梢血バフィー
コート、臍帯血等を予め血液バック1に入れておく。こ
の時、クランプ13は「閉」、三方活栓11はチューブ
9の方向が「閉」、三方活栓12はチューブ8の方向が
「閉」の状態にする。血液バック1内の細胞液は、第1
のチューブ6を通じて白血球除去フィルター2に導入さ
れる。そこで白血球は捕捉され、赤血球、血小板は通過
し第2のチューブ7から排液バッグ3に回収される。な
お、フィルター2に残存する若干の赤血球を洗流するた
めにクランプ13を「開」にし、回収バッグ4からチュ
ーブ10、第1のチューブ6、白血球除去フィルター
2、第2のチューブの順に回収液を排液バック3に流
す。次に、クランプ13を「閉」にし、三方活栓12の
第2のチューブ7(排液バッグ側)の方向が「閉」、三
方活栓11の第1のチューブ6(血液バッグ側)の方向
が「閉」となるようにする。そして回収液バッグ4を強
く押し潰すことにより、回収液を白血球除去フィルター
2に導入し、該フィルターに捕捉された白血球を押し出
し、第4のチューブ9を通して白血球回収バッグ5に流
す。白血球回収バッグ5に回収された細胞液は、このま
ま、あるいは濃縮操作により体積を減らしてから患者に
輸注したり、凍害保護剤の添加等の必要な作業を加え冷
凍保存を行い大量療法後に解凍して患者に輸注するとい
ったように利用される。
Embodiment 1 One example of an embodiment of the present invention will be described with reference to the drawings. 1 is a container containing raw material cells (usually a blood bag)
And is connected to the first tube 6. Reference numeral 4 is a bag containing the recovery liquid, from which the recovery liquid is supplied to the leukocyte removal filter 2. The third tube 8 is a tube for supplying the recovery liquid to the filter means 2 and is connected to the second tube 7. A clamp 14 is provided in the middle of the third tube, and a three-way stopcock 12 is provided at a branch point between the third tube 8 and the second tube 7. The tube 10 is a tube for introducing the rinse liquid into the filter means 2, and is branched from the first tube 6 by a Y-shaped tube or the like. There is a clamp 13 in the middle of the tube 10. First
Clamp 16 on tube 6 and trap with mesh 1
Those with 5 are desirable. The fourth tube 9 is for introducing the recovered cell liquid into the white blood cell recovery unit 5. First
There is a three-way stopcock 11 at the branch point between the tube 6 and the fourth tube 9. The filter means 2 is a filter that passes red blood cells (and platelets when it is desired to remove platelets) but traps white blood cells. The bag used for each of the means 1, 3, 4, and 5 can be connected to the tube by a spike or an aseptic connector. Next, the usage method will be described. First, bone marrow, peripheral blood buffy coat, umbilical cord blood and the like collected by a conventional method are put in the blood bag 1 in advance. At this time, the clamp 13 is in the “closed” state, the three-way stopcock 11 is in the “closed” direction of the tube 9, and the three-way stopcock 12 is in the “closed” direction of the tube 8. The cell fluid in the blood bag 1 is
It is introduced into the leukocyte removal filter 2 through the tube 6. There, the white blood cells are captured, the red blood cells and the platelets pass, and are collected in the drainage bag 3 from the second tube 7. In addition, the clamp 13 is opened to wash away some red blood cells remaining in the filter 2, and the collection solution is collected from the collection bag 4 to the tube 10, the first tube 6, the leukocyte removal filter 2, and the second tube in this order. To the drainage bag 3. Next, the clamp 13 is closed, the direction of the second tube 7 (drainage bag side) of the three-way stopcock 12 is “closed”, and the direction of the first tube 6 of the three-way stopcock 11 (blood bag side) is changed. Make it "closed". Then, by strongly crushing the recovery solution bag 4, the recovery solution is introduced into the leukocyte removal filter 2, the leukocytes captured by the filter are pushed out, and the leukocyte recovery bag 5 is caused to flow through the fourth tube 9. The cell fluid collected in the leukocyte collection bag 5 is infused into the patient as it is or after the volume is reduced by a concentration operation, or is cryopreserved by performing necessary work such as addition of a frost damage protector and thawed after mass therapy. It is used to infuse patients.

【0006】[0006]

【発明の効果】本発明によれば、遠心分離器や特殊な試
薬を用いない、簡便で低コストで短時間で操作でき、且
つ無菌操作ができる赤血球除去システムを提供すること
ができる。
According to the present invention, it is possible to provide a red blood cell removal system which does not use a centrifuge or a special reagent, is simple, can be operated at low cost in a short time, and can be operated aseptically.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明の「赤血球除去システム」の概略図であ
る。
FIG. 1 is a schematic view of a “red blood cell removal system” of the present invention.

【符号の説明】[Explanation of symbols]

1 血液バッグ 2 白血球除去フィルター 3 排液バッグ 4 回収液バッグ 5 白血球回収バッグ 6 第1のチューブ 7 第2のチューブ 8 第3のチューブ 9 第4のチューブ 10 フィルターリンス用チューブ 11,12 三方活栓 13 クランプ 14 クランプ 15 メッシュ入りトラップ 16 クランプ 1 Blood Bag 2 Leukocyte Removal Filter 3 Drainage Bag 4 Collection Fluid Bag 5 Leukocyte Collection Bag 6 First Tube 7 Second Tube 8 Third Tube 9 Fourth Tube 10 Filter Rinse Tube 11, 12 Three-way Stopcock 13 Clamp 14 Clamp 15 Mesh trap 16 Clamp

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 採取された原料細胞液を貯留する手段1
と、赤血球は通過し白血球は捕捉するフィルター手段2
と、該フィルター手段2より流出した赤血球含有液を貯
留する手段3とがそれぞれ第1及び第2のチューブを介
して直列に接続されており、前記フィルター手段下流の
第2のチューブ7から分岐した第3のチューブ8に接続
する回収液貯留部4と、前記フィルター手段上流の第1
のチューブ6から分岐した第4のチューブ9に接続する
白血球回収部5を具備し、且つ第2と第3のチューブの
分岐点には前記回収液貯留部4からフィルター手段2の
方向のみへ流通せしめるための手段を、第1と第4のチ
ューブの分岐点には前記フィルター手段2から前記白血
球回収部5の方向のみへ流通せしめるための手段を有す
ることを特徴とする赤血球除去システム。
1. A means 1 for storing the collected raw material cell fluid.
And filter means 2 for passing red blood cells and capturing white blood cells
And a means 3 for storing the erythrocyte-containing liquid flowing out from the filter means 2 are connected in series via first and second tubes, respectively, and branched from the second tube 7 downstream of the filter means. The recovered liquid storage part 4 connected to the third tube 8, and the first upstream of the filter means.
A leukocyte recovery part 5 connected to a fourth tube 9 branched from the second tube 6 and flowing only from the recovery liquid storage part 4 to the filter means 2 at the branch point of the second and third tubes. An erythrocyte removal system characterized in that it has means for urging it at a branch point between the first and fourth tubes so as to circulate it only from the filter means 2 toward the leukocyte recovery part 5.
【請求項2】 回収液貯留部4から第1のチューブ6へ
連結する、前記フィルター手段2のリンス用チューブ1
0を有する請求項1記載の赤血球除去システム。
2. The rinsing tube 1 of the filter means 2 which is connected to the first tube 6 from the recovered liquid storage section 4.
The red blood cell removal system according to claim 1, having 0.
JP23896895A 1995-08-25 1995-08-25 Erythrocyte removal system Expired - Lifetime JP3722523B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP23896895A JP3722523B2 (en) 1995-08-25 1995-08-25 Erythrocyte removal system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23896895A JP3722523B2 (en) 1995-08-25 1995-08-25 Erythrocyte removal system

Publications (2)

Publication Number Publication Date
JPH0956813A true JPH0956813A (en) 1997-03-04
JP3722523B2 JP3722523B2 (en) 2005-11-30

Family

ID=17037976

Family Applications (1)

Application Number Title Priority Date Filing Date
JP23896895A Expired - Lifetime JP3722523B2 (en) 1995-08-25 1995-08-25 Erythrocyte removal system

Country Status (1)

Country Link
JP (1) JP3722523B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006160731A (en) * 2004-11-11 2006-06-22 Kuraray Medical Inc Blood ingredient-recovering apparatus
JP2008220417A (en) * 2007-03-08 2008-09-25 Jms Co Ltd Extracorporeal circulation apparatus

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006160731A (en) * 2004-11-11 2006-06-22 Kuraray Medical Inc Blood ingredient-recovering apparatus
JP2008220417A (en) * 2007-03-08 2008-09-25 Jms Co Ltd Extracorporeal circulation apparatus

Also Published As

Publication number Publication date
JP3722523B2 (en) 2005-11-30

Similar Documents

Publication Publication Date Title
AU731766B2 (en) Cell separation method
US5215927A (en) Method for immunoselection of cells using avidin and biotin
JP4336399B2 (en) Blood separation device for blood components
US9480786B2 (en) Component preparation system
JPH0720490B2 (en) Device for processing cells contained in cell suspension
WO2005035737A1 (en) Method of preparing cell concentrate and cell composition
EP0260280B2 (en) Immunoselection method
US5225353A (en) Method for immunoselection of cells using avidin and biotin
JPWO2002101029A1 (en) Method for separating and enriching cells for kidney regeneration
JPH114682A (en) Preservation of nucleated cells, composition for the same and segregation of yukakusaihou
JP2003304865A (en) Method for separating cell
JP3722523B2 (en) Erythrocyte removal system
JPH08104643A (en) Method for removing erythrocyte
JPH09121849A (en) Cell collection system and cell collection
Cullis et al. Nucleated Cell Separation Using the Fenwal CS3000™
JPH09121850A (en) Two-stage cell concentration system and cell concentration
Zingsem et al. Automated processing of human bone marrow grafts for transplantation
JP3945725B2 (en) Cell separation method
JPS5854130B2 (en) Leukocyte separation method
Loos et al. Leukocyte depletion: a biotechnical transfusion story
JP4043094B2 (en) Cell separator
Amer et al. Lymphocyte, granulocyte and platelet contamination of blood frozen by the low‐glycerol liquid nitrogen technique
JP3938973B2 (en) Cell separation method
JPH09322758A (en) System and method of suitable for extracorporeal amplification cell separation
Zingsem et al. Bone marrow processing with the Fresenius AS 104: initial results

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20041228

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050401

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20050912

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20050913

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080922

Year of fee payment: 3

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090922

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090922

Year of fee payment: 4

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090922

Year of fee payment: 4

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100922

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110922

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110922

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120922

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130922

Year of fee payment: 8

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130922

Year of fee payment: 8

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

EXPY Cancellation because of completion of term